Wang SE - Search Results

1

Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.

Ghosh R, Narasanna A, Wang SE, Liu S, Chakrabarty A, Balko JM, González-Angulo AM, Mills GB, Penuel E, Winslow J, Sperinde J, Dua R, Pidaparthi S, Mukherjee A, Leitzel K, Kostler WJ, Lipton A, Bates M, Arteaga CL. Ghosh R, et al. Among authors: wang se. Cancer Res. 2011 Mar 1;71(5):1871-82. doi: 10.1158/0008-5472.CAN-10-1872. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324925 Free PMC article.

2

Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.

Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Ueda Y, et al. J Biol Chem. 2004 Jun 4;279(23):24505-13. doi: 10.1074/jbc.M400081200. Epub 2004 Mar 24. J Biol Chem. 2004. PMID: 15044465 Free article.

3

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

Wang SE, Wu FY, Shin I, Qu S, Arteaga CL. Wang SE, et al. Mol Cell Biol. 2005 Jun;25(11):4703-15. doi: 10.1128/MCB.25.11.4703-4715.2005. Mol Cell Biol. 2005. PMID: 15899872 Free PMC article.

4

Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.

Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL. Wu FY, et al. Among authors: wang se. Cancer Res. 2006 Feb 15;66(4):2162-72. doi: 10.1158/0008-5472.CAN-05-3304. Cancer Res. 2006. PMID: 16489017

5

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

Wang SE, Narasanna A, Perez-Torres M, Xiang B, Wu FY, Yang S, Carpenter G, Gazdar AF, Muthuswamy SK, Arteaga CL. Wang SE, et al. Cancer Cell. 2006 Jul;10(1):25-38. doi: 10.1016/j.ccr.2006.05.023. Cancer Cell. 2006. PMID: 16843263 Free article.

6

Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy.

Biswas S, Criswell TL, Wang SE, Arteaga CL. Biswas S, et al. Among authors: wang se. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4142-6. doi: 10.1158/1078-0432.CCR-06-0952. Clin Cancer Res. 2006. PMID: 16857784 Review. No abstract available.

7

Gene targeting of ErbB3 using a Cre-mediated unidirectional DNA inversion strategy.

Qu S, Rinehart C, Wu HH, Wang SE, Carter B, Xin H, Kotlikoff M, Arteaga CL. Qu S, et al. Among authors: wang se. Genesis. 2006 Oct;44(10):477-86. doi: 10.1002/dvg.20243. Genesis. 2006. PMID: 16991114

8

HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.

Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL. Wang SE, et al. Cancer Res. 2006 Oct 1;66(19):9591-600. doi: 10.1158/0008-5472.CAN-06-2071. Cancer Res. 2006. PMID: 17018616

9

Multivariable difference gel electrophoresis and mass spectrometry: a case study on transforming growth factor-beta and ERBB2 signaling.

Friedman DB, Wang SE, Whitwell CW, Caprioli RM, Arteaga CL. Friedman DB, et al. Among authors: wang se. Mol Cell Proteomics. 2007 Jan;6(1):150-69. doi: 10.1074/mcp.D600001-MCP200. Epub 2006 Oct 5. Mol Cell Proteomics. 2007. PMID: 17028091 Free article.

10

Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells.

Wang SE, Narasanna A, Whitell CW, Wu FY, Friedman DB, Arteaga CL. Wang SE, et al. J Biol Chem. 2007 Feb 23;282(8):5661-9. doi: 10.1074/jbc.M608499200. Epub 2007 Jan 4. J Biol Chem. 2007. PMID: 17204482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters